europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

Webinar Report: Measuring the Economic Footprint of the Biotechnology Industry in Europe

05/03/2021
NEWS RELEASE
All Speakers

Webinar Report: Measuring the Economic Footprint of the Biotechnology Industry in Europe

On March 4, 2021, EuropaBio hosted the event ‘Measuring the Economic Footprint of the Biotechnology Industry in Europe’ to showcase the same-titled report.

The study, from the WifOR Institute, looked at the economic impact of the biotechnology industry within the (then) 28 European member states, in terms of gross value added (GVA), employment and trade in 2018.

European GDP benefitted by €38.5 bn and, including spill over effects, that number rises to €78.7bn. The direct contribution adds up to about 1.5% of total industrial GVA within the countries assessed, supported by 223,000 direct jobs rising to over 700,000 with associated employment.

The event brought together the report authors to present their findings in full, and a panel discussion with EuropaBio Members BASF, Gilead, and Bio.be/Essenscia to plot the future economic pathway for biotechnology across sectors.

The webinar then closed with EuropaBio Council Directors Bernard Grimm and Agnes Borg presenting industry policy and regulatory priorities from Members, where EuropaBio works to achieve the robust ecosystem biotechnology economic and societal contributions.

The full webinar recording is available HERE.

The webinar slides are available for download BELOW.

SLIDES
Measuring the Economic Footprint of the Biotechnology Industry in Europe


Download
20210304_Economic_Footprint_SLIDESDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

23/03/2023

Unlocking the Potential of Biotechnology Innovation for Patients


Read more
07/03/2023

Disc Medicine joins EuropaBio: life-changing medicines for patients with hematologic disorders


Read more
06/03/2023

Can the Pharmaceutical Strategy Deliver for Europe?


Read more
01/03/2023

Vlad Olteanu new Healthcare Public Affairs Director at EuropaBio


Read more

Important links

  • Unlocking the Potential of Biotechnology Innovation for Patients
  • Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies